Emily Leproust, Ph.D., Recognized as 2018 Upstart 50
SAN FRANCISCO--(BUSINESS WIRE)--Sep 7, 2018--Emily Leproust, Ph.D., CEO of Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, has been recognized as an honoree of the 2018 Upstart 50.
Award applicants were evaluated based on their business history, recent success or accomplishments and use of innovative practices or pathways to business creation. They were divided into four categories: The Inventors behind the companies and technologies changing the world, The Backers who support the region’s thriving entrepreneurial network, The Creatives blending design with emerging lines of business and The Masters who have made the Bay Area the place it is today by breaking barriers and being on the vanguard of the nation’s innovation.
“It’s truly a privilege to be recognized as an Upstart 50 honoree in an area rich with talent and innovation,” said Leproust. “We have built a tremendous organization, with operations both in San Francisco and South San Francisco, making DNA at an unprecedented scale to improve health and sustainability. Our customers use our products in diverse fields for everything from medical research to new biomaterials to agricultural products designed to reduce pesticides and even DNA for digital data storage.”
The Upstart 50 is an innovative publication and celebration that recognizes organizations that drive the creation of the world’s new innovation capital. The program is produced and presented by the San Francisco Business Times and the Silicon Valley Business Journal with its title sponsor CDW Corporation. The event to celebrate the honorees was held on September 6, 2018 in San Francisco.
About Twist Bioscience Corporation
At Twist Bioscience Corporation, we work in service of customers who are changing the world for the better. In fields such as health care, agriculture, industrial chemicals, academic research and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. We believe that the faster our customers succeed, the better for all of us, and we believe Twist Bioscience is uniquely positioned to help accelerate their efforts.
Our innovative silicon-based DNA synthesis platform provides precision at a scale that we believe is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at https://twitter.com/TwistBioscience.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180907005073/en/
CONTACT: Investor Contact:
Maeve Conneighton, 212-600-1902
Twist Bioscience Corporation
Angela Bitting, 925-202-6211
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: TECHNOLOGY NANOTECHNOLOGY HEALTH BIOTECHNOLOGY GENETICS RESEARCH OTHER SCIENCE SCIENCE
SOURCE: Twist Bioscience Corporation
Copyright Business Wire 2018.
PUB: 09/07/2018 08:00 AM/DISC: 09/07/2018 08:01 AM